Evidence map›Paper›PMID 36564713›Full record

ArticleBMC genomics2022

Machine learning framework for gut microbiome biomarkers discovery and modulation analysis in large-scale obese population.

Yaoliang Liu, Jinlin Zhu, Hongchao Wang, Wenwei Lu, Yuan Kun Lee, Jianxin Zhao, Hao Zhang

Abstract read
In one paragraph

Article in BMC genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Decoding the rhizosphere microbiome againstFrontiers in microbiomes · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. AI in microbiome-related healthcare.Microbial biotechnology · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Hepatoprotective Potential ofIn vivo (Athens, Greece)
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yaoliang LiuState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China.
Jinlin ZhuState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China. wx_zjl@jiangnan.edu.cn.
Hongchao WangState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China.
Wenwei LuState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China.
Yuan Kun LeeDepartment of Microbiology & Immunology, Yong Loo Lin School of Medicine, National University of Singapore, 21 Lower Kent Ridge Rd, Singapore, Singapore.
Jianxin ZhaoState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China.
Hao ZhangState Key Laboratory of Food Science and Technology, Jiangnan University, P. R, Wuxi, 214122, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe gut microbiome has proven to be an important factor affecting obesity; however, it remains a challenge to identify consistent biomarkers across geographic locations and perform precisely targeted modulation for obese individuals.

resultsThis study proposed a systematic machine learning framework and applied it to 870 human stool metagenomes across five countries to obtain comprehensive regional shared biomarkers and conduct a personalized modulation analysis. In our pipeline, a heterogeneous ensemble feature selection diagram is first developed to determine an optimal subset of biomarkers through the aggregation of multiple techniques. Subsequently, a deep reinforcement learning method was established to alter the targeted composition to the desired healthy target. In this manner, we can realize personalized modulation by counterfactual inference. Consequently, a total of 42 species were identified as regional shared biomarkers, and they showed good performance in distinguishing obese people from the healthy group (area under curve (AUC) =0.85) when demonstrated on validation datasets. In addition, by pooling all counterfactual explanations, we found that Akkermansia muciniphila, Faecalibacterium prausnitzii, Prevotella copri, Bacteroides dorei, Bacteroides eggerthii, Alistipes finegoldii, Alistipes shahii, Eubacterium sp. _CAG_180, and Roseburia hominis may be potential broad-spectrum targets with consistent modulation in the multi-regional obese population.

conclusionsThis article shows that based on our proposed machine-learning framework, we can obtain more comprehensive and accurate biomarkers and provide modulation analysis for the obese population. Moreover, our machine-learning framework will also be very useful for other researchers to further obtain biomarkers and perform counterfactual modulation analysis in different diseases.

Indexed as

Gastrointestinal MicrobiomeBiomarkersFecesHumansMachine LearningObesityBiomarkersCounterfactual explanationEnsemble learningGeographyGut microbiomeMachine learningObesityReinforcement learning

Identifiers

PMID36564713
PMCPMC9789565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.